Multiple Sclerosis, or MS, is a chronic and disabling disease that affects one out of every ten-thousand people, is most common among those of Northern European ancestry, and typically appears between the ages of twenty to thirty. MS is a progressive neurological disorder that affects the functions of the physical structures and systems of the body with symptoms ranging from numbness and lowered motor control of the limbs to paralysis and blindness. Many researchers believe that the cause is genetic, polygenetic at that where a very specific combination of genes from the mother and the father. The disease is marked by an overactive immune system that attacks neurons by stripping away a conductive coating. The result is that neurons no longer conduct the electrical signals from the brain efficiently and therefore act as a break in the line of communication. Treatment efforts have been on-going for decades and are currently focused on the development of pharmacological responses to the diseases. Most current is the use of a semi-estrogen hormone treatment in women. Research continues to be exceptionally valuable and will continue to be of importance to the community afflicted with MS. It is the purpose of this paper to examine the specific needs of patients with MS, the description of the disease, treatment, and the projected outcom
